POU3F2 regulates canonical Wnt signalling via SOX13 and ADNP to expand the neural progenitor population
Brain · 2025
DOI: 10.1093/brain/awaf221 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain, 2025. Verfasst von Courtney R Benoit und 13 weiteren Autor:innen. Beteiligte Einrichtung: Ann Romney Center for Neurologic Diseases, Department of Neurology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA. Hauptthemen laut MEDLINE: Neural Stem Cells, Wnt Signaling Pathway, Homeodomain Proteins, Nerve Tissue Proteins. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 120 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Dauten Family Foundation, Harvard Brain Science Initiative Bipolar Disorder Seed Grant, NIMH NIH HHS.
Abstract (Originalsprache)
Loss-of-function mutations in the transcription factor POU3F2 have been identified in individuals with neurodevelopmental disorders. To elucidate the mechanistic role of POU3F2 in human neurodevelopment, we induced POU3F2 disruption in human neural progenitor cells (NPCs). Mutation of POU3F2 in NPCs causes reduced baseline canonical Wnt signalling and decreased proliferation, resulting in premature specification of radial glia. Additionally, POU3F2 levels across genetically diverse NPCs significantly associate positively with baseline canonical Wnt signalling and negatively with markers of radial glia specification. Through a series of unbiased analyses, we show that SRY-box transcription factor 13 (SOX13) and activity dependent neuroprotector homeobox (ADNP) are transcriptional targets of POU3F2 which mediate POU3F2's effects on Wnt signalling in human NPCs. Finally, we describe five individuals with autism spectrum disorder that harbour loss-of-function mutations in POU3F2, enhancing the genetic evidence for its critical role in human neurodevelopment. Together, these studies define POU3F2 as an activator of canonical Wnt signalling and mechanistically link two high-confidence autism genes, ADNP and POU3F2, in the regulation of neurodevelopment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Ann Romney Center for Neurologic Diseases, Department of Neurology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA.
- Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Förderung
- Dauten Family Foundation
- Harvard Brain Science Initiative Bipolar Disorder Seed Grant
- NIMH NIH HHS
- NIA NIH HHS
- NIH HHS
- NIH
Zitieren
APA
Benoit, C. R., Sattler, L. B., Aylward, A. J., Pembridge, O., Kim, B., Muratore, C. R., Liao, M., He, A., Ashour, N., Fancher, S. B., Lish, A. M., Pearse, R. V., Buxbaum, J. D., & Young-Pearse, T. L. (2025). POU3F2 regulates canonical Wnt signalling via SOX13 and ADNP to expand the neural progenitor population. Brain. https://doi.org/10.1093/brain/awaf221
Vancouver
Benoit CR, Sattler LB, Aylward AJ, Pembridge O, Kim B, Muratore CR, et al. POU3F2 regulates canonical Wnt signalling via SOX13 and ADNP to expand the neural progenitor population. Brain. 2025. doi:10.1093/brain/awaf221
BibTeX
@article{Benoit2025,
author = {Benoit, Courtney R and Sattler, Lilia B and Aylward, Aimee J and Pembridge, Olivia and Kim, Bella and Muratore, Christina R and Liao, Meichen and He, Amy and Ashour, Nancy and Fancher, Seeley B and Lish, Alexandra M and Pearse, Richard V and Buxbaum, Joseph D and Young-Pearse, Tracy L},
title = {POU3F2 regulates canonical Wnt signalling via SOX13 and ADNP to expand the neural progenitor population},
journal = {Brain},
year = {2025},
doi = {10.1093/brain/awaf221}
}
EUVIMED